Macrocheilia as an Atypical Clinical Presentation of Capillary Malformation-Arteriovenous Malformation Type 2. This case report describes a 53-year-old man with multiple erythematous macules and papules diffusely distributed on the frontal area, cheeks, eyelids, nose, and supralabial skin.
Reconstruction of Macrocheilia on the Lower Lip Through Bilateral Limited Excision and a Stepwise Single-Stage Approach (BLESS). The surgical management of macrocheilia secondary to port-wine stains is complicated. This study aimed to propose an innovative method for treating macrocheilia on the lower lip. Patients who underwent the reconstruction of macrocheilia on the lower lip through the innovative approach were examined. Their preoperative and postoperative standard photographs were taken to evaluate the changes in lip length and thickness. The scores on Vancouver scar scale (VSS) and visual analog scale (VAS) were evaluated. Thirty-two patients who underwent the reconstruction of macrocheilia were examined. A follow-up of 12.2 months (6-36 months) was conducted. The lower lip contour
Somatic GNAQ mutation in different structures of Port-wine Macrocheilia. Port-wine macrocheilia (PWM) involves a congenital, progressive capillary malformation that results in soft-tissue hypertrophy in the lips. Its aetiology has not yet been fully elucidated. To investigate frequencies of GNAQ mutation in different tissues from patients with PWM, including skin, mucosa, gland and muscle, using
Effectiveness of surgical treatment of severe macrocheilia in a patient with orofacial granulomatosis. Orofacial granulomatosis (OFG) is the term given to a group of diseases characterized by the presence of non-necrotizing granulomatous inflammation affecting the soft tissues of the orofacial region. Treatment of OFG is often challenging and unsatisfactory. We report on a 32-year-old man
(eg, injury to the eye or facial nerve) Most lesions cannot be resected completely; therefore, the extent of the resection needs to be defined before the procedure.Next: EpidemiologyFrequencyLymphatic VMs are the most common bases for macrocheilia, macroglossia, macrotia, and macromelia. [5] Combined lymphaticovenous malformation (LVM) occurs particularly in the craniofacial region. [6] Previous
-year-old woman who had taken alendronate. Intraoral clinical examination demonstrated hypersalivation and macrocheilia of the lower lip, associated with an ill-defined ulcer with erythematous borders measuring 20 mm in greatest diameter and covered with serofibrinous exudates. The aging of the population in developed and developing countries has increased the use of alendronate sodium to prevent
Persistent lip enlargement: An unusual presentation of lupus erythematosus Macrocheilia is a challenging problem with a variety of underlying causes that are both local and systemic, and granulomatous causes underlie the majority of cases. In this study, we report on a 31-year old man who presented with a chronic lower lip enlargement and a nodular submental erythematous lesion. He was otherwise
(eg, injury to the eye or facial nerve) Most lesions cannot be resected completely; therefore, the extent of the resection needs to be defined before the procedure.Next: EpidemiologyFrequencyLymphatic VMs are the most common bases for macrocheilia, macroglossia, macrotia, and macromelia. [5] Combined lymphaticovenous malformation (LVM) occurs particularly in the craniofacial region. [6] Previous
] For patient education information, see the Aesthetic Medicine Resource Center.Next: ProblemThe purpose of lip reduction is not always purely cosmetic. Macrocheilia, or excessively prominent lips, may interfere with oral function, with an inadequate seal between the upper and lower lips resulting in incompetence and drooling. It can also interfere with speech patterns and functionality and can alter self -perception and confidence, since the condition can sometimes be a source of ridicule and a target of bullying. Macrocheilia, which is more prevalent in certain ethnic groups, has multiple etiologies and can affect one or both lips. (See the image below.)Frontal and profile view of a 45-year-old African American woman seeking reduction of her upper lip. View Media Gallery Previous Next: EtiologyMacrocheilia
D, Joos U. Surgical treatment of persistent macrocheilia in patients with Melkersson-Rosenthal syndrome and cheilitis granulomatosa. Arch Dermatol. 2005 Sep. 141(9):1085-91. [QxMD MEDLINE Link]. 46. Tan Z, Zhang Y, Chen W, Gong W, Zhao J, Xu X. Recurrent facial palsy in Melkersson Rosenthal syndrome: total facial nerve decompression is effective to prevent further recurrence. Am J
D, Joos U. Surgical treatment of persistent macrocheilia in patients with Melkersson-Rosenthal syndrome and cheilitis granulomatosa. Arch Dermatol. 2005 Sep. 141(9):1085-91. [QxMD MEDLINE Link]. 46. Tan Z, Zhang Y, Chen W, Gong W, Zhao J, Xu X. Recurrent facial palsy in Melkersson Rosenthal syndrome: total facial nerve decompression is effective to prevent further recurrence. Am J
Surgical treatment of persistent macrocheilia in patients with Melkersson-Rosenthal syndrome and cheilitis granulomatosa. Various conservative methods for treatment of labial swelling in patients with cheilitis granulomatosa have been attempted, often with only moderate success and sometimes with persistent disfiguring lip swelling. Severe macrocheilia can produce an unaesthetic facial deformity associated with functional disturbances. In patients with persistent macrocheilia, reduction cheiloplasty with excision of excess tissue may be indicated when conservative treatment has proven ineffective in reducing swelling but may have been successful in stabilizing disease. To evaluate long-term results after reduction cheiloplasty in patients with macrocheilia caused by Melkersson-Rosenthal syndrome
Chronic macrocheilia: a clinico-pathological study of 28 patients. Chronic macrocheilia has a multifactorial aetiology and is often a diagnostic and therapeutic challenge. Epidemiological information on this condition is scarce, most of the data reported relating only to granulomatous cheilitis. We have performed a detailed clinico-pathological analysis of all patients with chronic macrocheilia presenting to us during the last 6.5 years. Of the 28 patients identified, 13 (46.4%) had granulomatous cheilitis (GC), six (21.4%) had tuberculosis of the lip, three (10.7%) had leprous macrocheilia, two (7.1%) had multiple endocrine neoplasia type IIb, and one each had Ascher's syndrome and non-Hodgkin's lymphoma. Two patients were diagnosed as 'nonspecific cheilitis'. Histopathological differentiation